Senseg, which is developing technology for touchscreen interfaces, has secured $6m in a series B round supported by NXP.

UK-based Aveillant has now raised about $21.7m from investors including ESB and original parent company Cambridge Consultants.

The commercialisation agreement will run for an initial pilot phase of 18 months.

The Legend Holdings-backed aortic valve medical device developer has extended its series C by a further $10m after reaching a $62.5m first close last year.

HGTF has received financing from Germany-based pharmaceutical company Bayer, which has become the twentieth investor in its High-Tech Gruenderfonds II fund.

European accelerator programme Startupbootcamp has secured support from corporates including Nokia, Bosch, Cisco and Castrol for its Berlin accelerator, which will connect with San Francisco.

The University of Ulster reports commercialisation success adding to Northern Ireland's economic recovery.

The contribution of UK universities to the British economies increases by 24%.